ANRS 12249 TasP

Phase:Open Label
Principal Investigator(s):
Objective:Impact of Immediate versus WHO Recommendations Guided ART Initiation on HIV incidence. Effectiveness of TasP in reducing HIV incience at the population-level.
Prevention Option(s):Treatment U=U
Study Design:Controlled, Randomized
Trial Sponsors: ANRS
Start Date
End Date
January 31, 2011
December 31, 2015
Age range: ↔ any
Population:Cisgender Men, Cisgender Women, People Living with HIV